Remdesivir for Covid-19: $1.6 Billion for a “Modestly Beneficial” Drug?

Islam Times - The U.S. Department of Health and Human Services has recently “bought” all of Gilead Science’s Remdesivir for $1.6 billion. “500,000 doses at $3,200 per patient – to be available to American hospitals but not for other countries”

from Islam Times - Latest News https://ift.tt/2O1OovV

• Twitter
• Facebook
• Google
• Tumblr
• Pinterest

About Arsalan